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Abstract
Background: Long standing Hashimoto Thyroiditis (HT) causes shrinking and atrophy of the thyroid, but may also
lead to diffuse enlargement of the gland and/or formation of nodules. These nodules should be differentiated from
papillary thyroid carcinoma (PTC) and primary thyroidal non-Hodgkin lymphoma (PTL), which are possible
complications of HT, and require pre-surgical diagnoses and different treatments.
This study focuses on the role of fine-needle cytology (FNC) in the clinical surveillance and pre-surgical diagnosis
of HT with diffuse and nodular enlargement of the gland in elderly patients.
Methods: Thirty-four elderly patients (≥ 65 yrs) with HT and diffuse or nodular enlargement of the thyroid
underwent ultrasound (US)-guided FNC. Smears were routinely stained and evaluated; additional passes were used
for flow cytometry (FC) assessment of lymphoid infiltrate in 6 cases.
Results: The cytological diagnosis was HT in 12 cases with prevalence of Hurtle cells in 2 cases, PTC in 1 case and
PTL in 2 cases. FC assessed the reactive, non-lymphomatous nature of the lymphoid infiltrate in 5 cases and
demonstrated light chain restriction, hence the lymphomatous nature of the lymphoid infiltrate in 2 cases of PTL.
Conclusions: FNC plays a key role in the clinical surveillance and pre-surgical diagnosis of diffuse enlargement and
nodular presentation of HT in elderly patients. FNC can correctly diagnose HT, PTC and PTL indicating the need for
surgery and its extension in suspicious or neoplastic cases, leaving other cases to the medical treatment and
clinical surveillance.
Introduction
Hashimoto Thyroiditis (HT) is the most common auto-
immune disease; the typical clinical presentation is a
painless diffuse enlargement of the thyroid, with high
serum thyroid autoantibodies [1,2]. HT is characterized
by the progressive loss of follicular cells and their con-
comitant replacement by a lymphoid infiltrate (TLI)
with the formation of germinal centers and fibrosis[1-3].
HT patients have high levels of serum thyroid autoanti-
bodies which include antithyroid peroxidase (anti-TPO),
antithyroglobulin (anti-Tg), whereas a percentage of
patients (10-15%) may be antibody negative. An increase
in the serum thyroid stimulating hormone (TSH), in any
phase of the disease, heralds incipient hypothyroidism
[3]. Lymphoid infiltrate in HT release in situ a number
of factors, including cytokines, that increase the intracel-
lular generation of reactive oxygen species (ROS). ROS
have important cellular and tissue effects and are
responsible for senescence, cancer and other age-related
diseases [4-6]. Over time, the gland progressively shrinks
causing almost complete atrophy but, in many patients
and/or in different phases of the disease, there is a sym-
metrical or asymmetrical enlargement of the gland with
nodule formation [7,8]. Indeed, US presentation of HT
varies significantly, ranging from a normal thyroid par-
enchyma imaging to diffuse homogeneous enlargement
or atrophy, up to uninodular or multinodular presenta-
tion in +/-50% of cases [7,8]. Nodule US appearance is
also extremely variable: nodules may be hypo or hyper
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echoic, can have calcifications (micro and scattered,
macro or eggshell calcifications), and may also show a
hypoechoic halo [7,8]. With reference to the clinical
behavior, possible HT complications include papillary
carcinoma (PTC) [9-11] and, rarely, primary non-Hodgkin
lymphoma (PTL) [3,12-14], in addition to hypothyroidism
[1,15,16]; therefore a direct evaluation of diffuse or
nodular thyroid enlargement in case of HT may be
needed. The clinical appearance of thyroid cancer is that
of a nodules, some time representing a challenging diag-
nostic dilemma with thyroid or unusual extrathyroidal
masses [17,18]. Fine-needle cytology (FNC) is widely used
in the diagnosis of thyroid nodules [18-20], and the appli-
cation of molecular techniques to FNC has dramatically
increased its sensitivity [3,21-29], including in cases of HT
with diffuse or nodular enlargement [3]. An effective FNC
diagnosis avoids useless diagnostic surgery or leads to the
proper surgical treatment, when needed [30][18]. These
advantages are enhanced in the case of HT which does
not require surgical treatment, especially in elderly
patients in which any surgery is generally more burden-
some, complex and expensive than younger patients
[31,32]. The aim of this study is to assess the role of FNC
in the clinical surveillance and pre-surgical diagnosis of
thyroidal diffuse enlargement and HT nodules in elderly
patients.
Materials and methods
Between January 2010 and December 2012, 1.256
patients with thyroidal nodules or diffuse swelling
underwent FNC in the outpatient clinics of the Azienda
Ospedaliera Universitaria, University of Salerno. Before
FNC, patients were informed of the diagnostic proce-
dure and related risks; informed consent was obtained
from all patients for the performance of FNC, diagnostic
procedures and the scientific use of biological material.
Sixty patients were diagnosed with HT or suspected HT
because of the clinical, serologic, and/or ultrasound (US)
presentation. Clinical signs and symptoms included
swollen thyroid gland, with or without discrete nodules
and, rarely, mild fever. US examination generally showed
poorly defined hypoechoic areas, thin fibrous strands
with diffuse hypervascular pattern or diffuse glandular
enlargement with scattered nodules. Clinical, serological
and US data were available for all patients and FNC pro-
duced a sufficient amount of cells to prepare adequate
cytological smears and perform ancillary techniques,
when needed. Whereas the definition of elderly is related
to the pathophysiology of aging [31-33], the criteria of
eligibility in the present study considered elderly patients
those older than 65 years [34], therefore we enrolled
14 patients (13 women and 1 man; age range 65-73 years).
All patients showed palpable nodular or diffuse enlarge-
ment of the thyroid, some of them received previous
pharmacologic treatments for thyroid pathologies and,
according to the US pattern, they were classified as “nodular”
in 12 cases and “diffuse” in 2 cases. Serologic assessment
for TSH, free triiodothyronine (FT3), free thyroxine (FT4),
thyroglobulin antibodies and thyroid peroxidase antibodies
(TPO-AB) was performed in all cases. The median values
were as follows: TSH: 2.8 U/L (range, 0.9- 16.1 U/L); free
triiodothyronine (FT3): 3.4 pg/mL (range, 2.9-4.0 pg/mL);
free thyroxine (FT4): 12.1 pg/mL (range, 8.0-14.3 pg/mL);
thyroglobulin antibodies (Tg-AB): 212 U/L (range,
86-1240 U/L); and thyroid peroxidase antibodies
(TPO-AB): 89 (range, 48-612 U/L).
Fine-needle cytology
The diagnostic procedure and related risks were first
discussed with the patients, who were also informed
that 1 or 2 supplementary passes might have been
needed, and their informed consent was obtained. FNC
was performed under US control, as previously
described [35,36], and 2 or more smears were prepared
according to the amount of material obtained. In 20
cases, a rapid on site evaluation (ROSE) on Diff-Quik
stained smears was performed as described elsewhere
[36]. In 8 cases showing scanty cellular material, the
procedure was repeated immediately or after a week,
when ROSE was not performed. On the basis of the
ROSE evaluation, a second pass was used in 6 cases to
prepare additional smears and/or cell suspension for
flow cytometry (FC) assessment of the lymphoid cell
populations, as previously described [37-39]. According
to the standard cytologic criteria [40], the diagnosis of
HT was made on the basis of a lymphoid cell infiltrate,
the presence of stretched lymphocytes, and multinu-
cleated giant cells, if any. Follicular cells and Hurthle
cells had to be present in variable numbers and were
re-evaluated according to the current diagnostic criteria.
FC data were interpreted accordingly [3] in this specific
clinical and anatomical setting. With regard to the light
chain evaluation for clonal assessment of lymphoid cell
populations, a percentage of the gated cells showing /l
unbalance ≤ 20% of the gated cells was considered as an
evidence of clonality [3,41]. FC assessment was used to
perform the final diagnosis and was included in the
cytological reports. All the cytological diagnoses were
confirmed by the clinical, serologic, and US follow-up in
case of HT and by histological examination in 2 cases
cytologically diagnosed as PTC (case 1) and PTL (case 2),
respectively.
Results
The cytological diagnosis was typical HT in 10 cases,
HT with prevalence of Hurthle cells in 2 cases, PTC in
1 case and PTL in 1 case. Typical HT showed different
cytological patterns due to the prevalence of lymphoid
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cells or follicular and Hurthle cells. Those with prevalence
of lymphoid cells were characterized by small lympho-
cytes, either isolated or intermingled with histiocytes,
occasional plasma cells, and stretched lymphocytes. This
pattern was referred as ‘’lymphocytic’’ (6 cases) (Figure 1).
In addition to the small lymphocyte and plasma cell popu-
lation, a second cell population was observed, having
larger lymphocytes and germinal center lymphoid cells.
These cells gave the smear a lymph node appearance,
referred to as ‘’lymph node-like’’ pattern (Figure 2)
(4 cases). In these cases, a differential diagnosis with a
possible Non-Hodgkin Lymphoma (NHL) was taken into
account and FC data confirmed the reactive, non lympho-
matous nature of the lymphoid infiltrate. Conversely,
FC demonstrated the clonal lymphomatous nature of the
lymphoid infiltrate in 2 PTL cases. In 2 cases, the preva-
lence of follicular cells and Hurthle cells was observed.
In these cases a differential diagnosis with Hurthle cell
neoplasm was taken into account; nonetheless the poly-
morphism of the cells, the concomitant presence of
lymphoid infiltrate and stretched lymphocytes supported
the diagnosis of HT. As for the neoplastic nodules, 2 cases
were diagnosed as PTL and 1 case as PTC on the basis of
cytological and FC data. PTL cases underwent syste-
mic screening and positron emission tomography (PET)
which assessed that thyroid was the only organ involved;
therefore, patients underwent hemithyroidectomy. The
histological examination confirmed the diagnosis of
mucosa-associated lymphoid tissue (MALT) and diffuse
large B-cell lymphoma (DLBCL). The patient who received
the diagnosis of PTC underwent total thyroidectomy and
radio metabolic therapy, being the cytological diagnosis
confirmed by histology. All PTL and PTC patients are
alive without signs of disease.
Discussion
HT clinical presentation reflects the pathological modifi-
cations of the gland over time. After an initial diffuse
swelling, the gland undergoes progressive loss of thyroid
follicular cells and replacement by lymphocytes, with the
formation of germinal centres and fibrosis. Apoptosis is
considered to be the main pathogenetic mechanism of
follicular cell destruction; a predominantly Th1-mediated
immune activity may promote apoptosis of thyroid folli-
cular cells, leading to thyroid cell destruction and
HT [42], although a direct cytotoxic mechanism is also
possible [43]. The gland is then colonized by B lympho-
cytes, which participate in the autoimmune process by
inducing the formation of autoantibodies and lymphoid
follicles. At the same time, the gland generally shrinks
and becomes atrophic. There is no evidence about the
involvement of bone marrow-derived non-haematopoietic
cell types, such as endothelial progenitor cells, which have
instead been associated to the pathogenesis of numerous
malignancies [44-46]. Hyperplastic foci of follicular cells,
accumulation of lymphoid cells, germinal centre structures
and fibrosis may cause symmetrical or nodular enlarge-
ment of the gland. Complications of long standing HT
include hypothyroidism and, more rarely, PTC or PTL.
Despite being extremely rare, the association between HT
and thyroid lymphoma has been assessed [47,48]; on the
other side, the relationship between HT and PTC has
been widely debated and it is still controversial [10].
Indeed, epidemiological studies highlight the coexistence
of HT in 10 - 35 % of PTC patients [10,47,49]. Numerous
mechanisms have been proposed to explain this associa-
tion, including the expression of the RET/PTC1 and RET/
PTC3 oncogenes in Hashimoto’s patients [50], as well as
Figure 1 Lymphoid cells were characterized by small
lymphocytes, either isolated or intermingled with histiocytes,
occasional plasma cells, and stretched lymphocytes; this pattern
was referred as ‘’lymphocytic’’ (Original magnification × 40).
Figure 2 Cells gave the smear a lymph node appearance,
referred to as ‘’lymph node-like’’ pattern (Original
magnification × 40).
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the coexistence of similar immunohistochemical patterns,
microscopic features and molecular rearrangement of the
RET/PTC gene [49,51]. The clinical management of thyr-
oid nodules, with or without HT, mainly depends on clini-
cal data, US and FNC, the latter being the gold standard
for the pre-surgical diagnosis of thyroidal nodules [40].
Despite the highest incidence of nodular thyroidal pathol-
ogies, more than 90% of the thyroid nodules are benign;
therefore, FNC plays the key role to exclude surgical treat-
ment of non-tumoral nodules. On the contrary, FNC may
indicate the need for lobectomy or thyroidectomy for the
neoplastic ones, on the basis of its results [18]. In this per-
spective, FNC plays a relevant role in the management of
elderly patients in which surgical treatments are less toler-
ated and have additional difficulties in comparison to
younger patients [32,52]. As far as HT is concerned, clini-
cal serological and US control are sufficient for the diag-
nosis and clinical management in most of the cases. When
HT shows nodules, masses or swelling at clinical and US
evaluation, a possible neoplastic complication has to be
ruled out. In these cases, FNC allows to assess the benign
inflammatory nature and to exclude possible neoplastic
complications. In case of cytological benign results,
the indication for medical or surgical treatment is then left
to the clinical and US evaluation. In case of tumoral
nodules, FNC not only indicates the need for surgical
treatment, but it can also be useful to draw up the follow-
ing diagnostic procedures, surgery extension and possible
additional treatments. In the present study, FNC proved to
be a reliable diagnostic tool to confirm the clinical-cytolo-
gical diagnosis of HT in its diffuse or nodular presentation.
It allowed the correct medical treatment and avoided the
surgical removal of nodules that would not have been
properly diagnosed. Indeed, FNC correctly identified
PTCs and PTLs, indicating the need and the extension
of therapeutic surgical treatment.
Conclusions
FNC has a definite role in the clinical surveillance and pre-
surgical diagnosis of thyroidal diffuse enlargement and
nodular presentation of HT; it can be conveniently used in
elderly patients. FNC can also indicate the need for sur-
gery and its extension in selected cases, as well as the need
for medical treatments and clinical surveillance in others.
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